Open Access

Impact factors for perioperative morbidity and mortality and repercussion of perioperative morbidity and long-term survival in pancreatic head resection


Cite

Surgical complications in 240 operated patients

Type of all surgical complications (n = 240)n%% 90-day mortality
No surgical complications16970.43
PF B or C2811.725
PF B or C and bleeding83.362.5
Bleeding in the intestines20.80
Intraabdominal bleeding – no PF41.725
Bile leak104.20
Leak from GEA52.120
Dehiscence of laparotomy31.30
Intraabdominal abscess62.50
Ileus10.40
Thrombosis of vascular graft20.80
Volvulus coeci10.40
Stenosis of coeliac trunk10.40
Total240100.07.9%

Observed clinicopathological features in 240 operated patients

P1 (n/%)P2 (n/%)All (n/%)p
male5180131
53.1%55.6%54.6%
Gender (n = 240)0.4
female4564109
46.9%44.4%45.4%
Age (n = 240)Mean (years)66.1 ± 9.965.98 ± 10.166.40.91
1174317
17.7%29.9%17.7%
ASA (n = 240)25368530.103
55.2%47.2%55.2%
3263326
27.1%22.9%27.1%
Preoperative histology (n = 240)432360.0001
4.2%22.2%15.0%
Hospital stay (n = 222)Mean (days)21.2 ± 14.519 ± 11.619.80.138
Preoperative total bilirubin (n = 240)Mean (mmol/l)(mmol/l)67.6 ± 71.579.0 ± 85.574.70.028
Preoperative endoscopic biliary drainage (EBD) (n = 240)3451850.554
35.4%35.4%35.4%
P1(n/%)P2(n/%)All(n/%)p
PD92115207
Type of pancreatic resection (n = 240)95.8%79.9%86.3%0.0001
TP42933
4.2%20.8%14.2%
Resection of VMS/VP (n=240)1228400.17
12.5%19.4%16.7%
Direct suture101424
Type of vascular reconstruction (n=240)10.4%9.7%10.0%0.043
Vascular graft21416
2.1%9.7%6.7%
Overall complications (OAC) (n=240)3455890.383
35.4%38.2%37.1%
30-day mortality (n=240)75120.152
7.3%3.5%5.0%
90-day mortality (n=240)118190.080
11.5%5.6%7.9%

Correlation of clinicopathological factors and perioperative morbidity and mortality in 240 operated patients

NOACPASCPBCPOLPAAPPLPAGCP
Age (years)240No compl.64.6 ± 100.00565.3 ± 10.30.05166.2 ± 100.45266 ± 100.665650 05665.7 ± 100.25665.4 ± 100.007
Compl.68.4 ± 9.167.9 ± 9.163.5 ± 1267.1 ± 87367.3 ± 870.1 ± 9
Age240<7028.6%0.01123.8%0.0718.6%0.0944.8%0.3690%0.03016.3%0.2348.6%0.021
(<70 and >69)>6943.7F%33.3%3.7%6.7%100%21.4%18.5%
ASA 1.2 vs. 3240ASA 1+232%0.00423.8%0.0425.5%0.4655.5%0.4650.45716.1%0.04210.5%0.006
ASA 352.5%33.3%6.8%6.8%29.5%25.4%
Total bilirubin240No compl.70.1 ± 740.27168.3 ± 73.60.06271 ± 770.00574.4± 780.9690.23168.1 ± 700.19579 ± 820.033
(mmol/l)Compl.82.9 ± 8989.5 ± 93.1134 ± 10475.5 ± 10891.4 ± 9947.4 ± 61
EBD240No EBD33.5%0.08224.5%0.0245.8%0.5947.1%0.2030.64012.8%0.00411.6%0.092
(no/yes)EBD43.5%37.6%5.9%3.5%30%18.8%
PD/TP240PD37.2%0.54529.5%0.4886.3%0.4005.8%0.6001%0.004--13%0.126
TP36.4%27.3%3%6.1%12.1%21.2%
Vasc. resect.240No vasc.39.5%0.11530.0%0.3344.5%0.0636%0.5780.73821.1%0.08316.5%0.011
(yes/no)Vasc. resect.27.5%25.0%12.5%5%7.7%2.5%
Size of tumor201No compl.32.3 ± 190.00131.7 ± 18.80.00229.5 ± 170.18729.4 ± 170.3200.06930.3 ± 180.00129.7 ± 170.211
(mm)Compl.24.6 ± 1223.7 ± 10.125 ± 1025.1 ± 1322.5 ± 925.7 ± 15
Type of tumor216PAC34.1%0.04226.7%0.0746.7%0.4215.9%0.4350.40316.2%0.09269.8 ± 1830.094
PAC/NPCNPC46.9%37.0%4.9%7.4%25.7%83.5 ± 127
Amylase level187No compl.21.3 ± 62.10.000124.0 ± 730.000168.6 ± 1750.33372.3 ± 180-0.77372.5 ± 1770.000122.2 ± 700.000169.8 ± 1830.640
(ukat/l)Compl.150.6 ± 252179.9 ± 270128.1 ± 19962.5 ± 1001.1 ± 1260 ± 31083.5 ± 127
Amylase187< 720.2%0.000111.4%0.00013.5%0.0221.7%0.00010.52919.1%0.000135.6%0.033
(>7 ukat/l)> 769.8%61.6%12.7%60.3%100%57.7%
PF C187No PF C33.1%0.000123.7%0.00013%0.00010.3180.81810.7%0.0001-0.464
(yes/no)PF C100%100%38.9%100%
PF B187No PF B33.1%0.000123.7%0.00016.5%0.6760.3180.81810.7%0.0001-0.221
(yes/no)PF B100%100%5.6%100%
PF A187No PF A42.5%0.03536.3%0.00010.1480.1710.73424%0.0001-0.141
(yes/no)PF A22.2%0100%
PF B or C187No PF B+C25.2%.0.000114.6%0.00012.6%0.00010.0880.655
PF B+C100%100%22.2
Period of the study240P135.4%0.38325.0%0.1552.1%0.0365.2%0.4850.23016.9%0.29217.70.137
P238.2%31.9%8.3%6.3%21.2%11.8
Hospital stay24014.2 ± 40.000115.2 ± 60.000119.3 ± 130.00318.1 ± 90.000119.6 ± 130.07517.8 ± 120.000118.4 ± 120.0001
(days)31.4 ± 1632.9 ± 1731.9 ± 844.9 ± 2929 ± 1030.7 ± 930.9 ± 10

General complications in 240 operated patients

Type of all general complications (n = 240)n%% 90-day mortality
No general complications20284.25.0
Pneumonia83.325
Cardiorespiratory decompensation31.3100
Heart failure93.811.1
Pulmonary embolism41.725
Different infections104.210
Renal failure1.4100
Brain stroke1.40
Miscellaneous2.80
Total240100.07.9

Indications for pancreatic resection

Indication for pancreatic resectionP1P2Allp
(n/ %)(n/ %)(n/ %)
Pancreatic adeno carcinoma6471135
66.7%50.0%56.7%
Neuroendocrine tumor of the pancreas279
2.1%4.9%3.8%
Main duct intraductal papillary mucinous neoplasm033
0.0%1.4%0.8%
Franz’s tumor101
1.0%0.0%0.4%
Non-Hodgkin lymphoma of the pancreas112
1.0%0.7%0.8%
Adenocarcinoma of the distal bile duct133043
13.5%20.8%17.9%
Adenocarcinoma of the papilla Vateri121830
12.5%12.5%12.5%
Duodenal adenocarcinoma268
2.1%4.2%3.3%
Gastric cancer022
0.0%1.4%0.8%
Chronic pancreatitis167
1.0%4.2%2.9%
eISSN:
1581-3207
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Radiology, Internal Medicine, Haematology, Oncology